Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
    - - FOR PATIENTS
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Contact Us
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Blog
        
        Brochures
        
        Manuals
        
        Studies
        
        Videos
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Brochures
        
        Manuals
        
        Podcasts
        
        Reports
        
        Studies
        
        Videos
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Blog
        
        Brochures
        
        Manuals
        
        Videos
        
        Webinars
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Blog
        
        Manuals
        
        Peer-reviewed Publications
        
        Posters
        
        Reports
        
        Videos
        
        Whitepapers
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        BESPOKE CRC
        
        BESPOKE IO
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Brochures
        
        Manuals
        
        Peer-reviewed Publications
        
        Podcasts
        
        Reports
        
        Studies
        
        Videos
        
        Webinars
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Blog
        
        Brochures
        
        Manuals
        
        Peer-reviewed Publications
        
        Webinars
        
        Videos
        
        Natera Academy Provider Education Hub
        
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Signatera
Assessment of circulating tumor (ct) DNA in patients (pts) with locally advanced rectal cancer (LARC) treated with neoadjuvant therapy (NAT)

Assessment of circulating tumor (ct) DNA in patients (pts) with locally advanced rectal cancer (LARC) treated with neoadjuvant therapy (NAT)

Published Date October 27, 2023

Fill form to unlock content

Loading, please wait

Error - something went wrong!

Please fill out form to access this item.

Thank you!

Previous Resource

Utility of circulating tumor (ct)DNA testing for molecular residual disease (MRD) detection and treatment response monitoring in patients
Next Resource

Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinom

Related Content

9 days ago
Using ctDNA to help inform the management of patients with low-risk colorectal cancer (with subtitles)

Watch Video
9 days ago
Using ctDNA to help inform the management of patients with locally advanced rectal cancer (with subtitles)

Watch Video
9 days ago
The expanding role of ctDNA in colorectal cancer to optimize patient management (with subtitles)

Watch Video
23 days ago
Personalized tumor-informed circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients rece

Oh, et al. Thorac Cancer. 2024;1–8.

Read More
30 days ago
Impact of Number of Variants in WES-based MRD Assays

Read More
about 1 month ago
How ctDNA can transform interventional trial design for GI cancers

Watch Video
about 1 month ago
US physician perspective on the use of biomarker and ctDNA testing in patients with melanoma

Rachel A. Fischer, et al. Critical Reviews in Oncology 2024

Read More
about 1 month ago
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detec

Aaron C. Tan, et al. Cancer, 2024

Read More
about 1 month ago
Early real-world experience monitoring circulating tumor DNA in resected early-stage non–small cell lung cancer

Travis K. Martin, el al. The Journal of Thoracic and Cardiovascular Surgery 2024

Read More
about 1 month ago
Utility of ctDNA in assessment of treatment response in patients with Recurrent/Metastatic Endometrial Cancer and Recurrent/Platinum-Resista

Read More
about 1 month ago
Personalized circulating tumor DNA analysis used for ctDNA detection and response monitoring in patients with advanced or recurrent uterine

Read More
about 1 month ago
PARPi response monitoring using personalized circulating tumor DNA testing in patients with ovarian cancer

Read More
about 1 month ago
Treatment Monitoring Utilizing ctDNA-based Molecular Residual Disease Detection in Early Stage Uterine Cancer

Read More
about 1 month ago
Utility of ctDNA as an Early Predictive Biomarker of Response to RT/CRT in Gynecologic Malignancies

Read More
about 1 month ago
Prognostic implications of minimal residual disease detection by second look laparoscopy and circulating tumor DNA in patients with ovarian

Read More
about 2 months ago
SSO Industry Spotlight 2024

Read More
Compassionate Care Application - Spanish

Read More
3 months ago
Seeing the Forest Through the Trees: How tumor informed MRD testing can illuminate the treatment pathway in GI cancer

Review recently presented MRD data in colorectal and pancreatic cancer, exploring the potential impact on patient care

Watch Video
3 months ago
Utility of circulating tumor DNA (ctDNA) for the detection of minimal residual disease (MRD) after curative-intent therapy for patients with

Read More
3 months ago
The role of pre-operative ctDNA in resectable intrahepatic cholangiocarcinoma

Read More

Return to Resource Library

© Natera, Inc.

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
Contact

Natera Licenses
IT Security Compliance
Natera Notice of Data Collection for California Residents
Privacy Practices
Privacy Policy
Terms of Use
Sitemap

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2024 Natera, Inc. All Rights Reserved.